7-OH Legal Status: DEA Scheduling Update (Oct 2026)
Updated Oct 20, 2026
The notice
On Oct 14, 2026 the DEA published a notice of intent (91 FR 65370) to temporarily place 7-OH in Schedule I above 1 mg/g, or where the mitragynine:7-OH ratio is below 100:1. A final order can issue on or after Nov 13, 2026.
What it means for shoppers
Concentrated 7-OH tablets would fall within the scheduled range. Natural leaf kratom with its typical alkaloid ratio is not covered by the notice.
Our policy
KratomTrail does not link to 7-OH concentrate products. Source: federalregister.gov/d/2026-20943.
21+ only. FTC: KratomTrail earns commissions from merchant links at no cost to you. FDA: These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any disease. Kratom is not FDA approved. Not for use if pregnant or nursing. Informational only, not legal or medical advice. Valdez Consultation LLC.